Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

Immunotherapy given during and after chemoradiation did not improve survival for study participants with limited-stage, small-cell lung cancer (SCLC) according to the results of an international ...

The U.S. Food and Drug Administration (FDA) declined approval of retifanlimab-dlwr for patients with metastatic non-small cell lung cancer (NSCLC) in the United States because of manufacturing ...

Sydney, Australia Monday, March 16, 2026, 10:00 Hrs [IST] ...

Incyte is looking to expand the use of its PD-1 blocker Zynyz to treat non-small cell lung cancer. The FDA’s rejection did ...

February 2026 coverage highlighted combination EGFR therapy guidance, chemo-free treatment options, biomarker testing and ...

Explore new strategies for treating resistant lung cancer. Discover how blocking growth hormone receptors may improve ...

Larotrectinib in Patients With Tumors With NTRK Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol EAY131-Z1E Advancements in profiling technologies have deepened our ...

Ohio University researchers have discovered what may be a new way to fight lung cancer that is resistant to other treatments.

Study to test RC220 alongside standard-of-care osimertinib to prevent or delay treatment resistance. ... Read More The post Racura secures green light for RC220 HARNESS-1 lung cancer trial appeared ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Shira Boehler's MRI results showing an abnormality in right lung At 43, Shira Boehler ...